Biolite Clinic in Jumeirah, Dubai, has become the first clinic in the Middle East to offer XERF, Cynosure Lutronic’s dual-frequency monopolar radiofrequency system. XERF was launched in Korea in 2024 and received clearance from the US Food and Drug Administration (FDA) in 2025. Since then, it has been adopted by more than 2,000 clinics worldwide […]
Read Full Story →
The Pharmaceutical Research and Manufacturers Association in Gulf (PHRMAG), the region’s leading innovative biopharmaceutical research companies, and the Authority of Social Contribution – Ma’an, the Abu Dhabi Government’s official channel to receive social contributions, has announced a strategic collaboration aimed at enabling access for oncology and rare disease patients most in need to innovative solutions […]
Read Full Story →
His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, launched ‘The Cancer More…
Read Full Story →
Wegovy® pill showed a mean weight loss of 16.6% in the OASIS 4 trial Wegovy® pill is indicated to reduce excess body weight and maintain weight reduction long-term and to reduce the risk of major adverse cardiovascular events* Novo Nordisk expects to launch Wegovy® pill in the US in early January 2026 Dubai, 24 December 2025- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Wegovy® pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse cardiovascular events*. The Wegovy®
Read Full Story →